NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/07/2023
Back to search
Official data from USPTO
HEALIOS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
65
Latest update
04/21/2023
Trademark type
Word
Nice classes
5
Filing date
06/26/2018
Registration date
02/07/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/07/2023
Last transaction
04/21/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
99
Owner location
Minato-ku, Tokyo, JP
Examiner
FOSDICK, GEOFFREY
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
H. K. (pessoa física)
Representatives
M. Scott Alprin ALPRIN LAW OFFICES PC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Cells for medical or clinical use; cells for medical or clinical use for treatment of diseases; stem cells for medical purposes; stem cells for veterinary purposes; surgical implants comprising living tissue grown from stem cells; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; biological preparations for the treatment of ophthalmiccentral nervousrespiratorycardiovascular disease; biological preparations for veterinary purposes for the treatment of cancerliver disease and immune system related disease; diagnostic preparations for medical and veterinary use; diagnostic reagents for medicinal use; veterinary diagnostic reagents; adjuvants for medical purposes; cytostatics for medical purposes; pharmaceutical preparations for activating cellular function for the treatment of cancerliver disease and immune system related disease; sanitary preparations for medical use; ophthalmic preparations; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for ocular or intraocular surgery; collyrium; eye drops; pharmaceutical agents affecting the central nervous system; pharmaceutical preparations for the peripheral nervous system; cardiovascular agents for medical purposes; cardiovascular treatment preparations; cardiovascular pharmaceuticals; cardiovascular pharmaceutical preparations; respiratory stimulants; pharmaceutical products for treating respiratory diseases; pharmaceutical preparations for the treatment of immune system related diseases and disorders; anti-inflammatories; pharmaceutical agents affecting digestive organs; pharmaceutical agents for treating physically caused lesions; opotherapy preparations; organotherapy preparations; gene therapy productsgenetically engineered tissues for transplant purposes; surgical implants comprised of living tissues; pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for use in the fields of anesthesiaoncologyurology and gynecology
Publications
History of USPTO decisions and trademark events.
65 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/07/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/22/2022
PUBO
PUBLISHED FOR OPPOSITION
11/22/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/02/2022
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
10/18/2022
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
10/14/2022
OTHE
CASE RETURNED TO EXAMINATION
10/12/2022
IUCN
NOTICE OF ALLOWANCE CANCELLED
10/12/2022
ATRQ
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
10/07/2022
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
10/07/2022
APET
ASSIGNED TO PETITION STAFF
10/05/2022
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
09/08/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/29/2022
EX4G
SOU EXTENSION 4 GRANTED
03/25/2022
EXT4
SOU EXTENSION 4 FILED
03/25/2022
EEXT
SOU TEAS EXTENSION RECEIVED
03/25/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/16/2021
EX3G
SOU EXTENSION 3 GRANTED
10/14/2021
EXT3
SOU EXTENSION 3 FILED
10/14/2021
EEXT
SOU TEAS EXTENSION RECEIVED
10/14/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/19/2021
EX2G
SOU EXTENSION 2 GRANTED
03/17/2021
EXT2
SOU EXTENSION 2 FILED
03/17/2021
EEXT
SOU TEAS EXTENSION RECEIVED
03/17/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/10/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/19/2020
EX1G
SOU EXTENSION 1 GRANTED
08/17/2020
EXT1
SOU EXTENSION 1 FILED
08/17/2020
EEXT
SOU TEAS EXTENSION RECEIVED
08/17/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/12/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/17/2020
PUBO
PUBLISHED FOR OPPOSITION
03/17/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/26/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/13/2020
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
02/12/2020
GEA1
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
11/08/2019
GECD
ACTION DENYING REQ FOR RECON E-MAILED
11/08/2019
CNCF
ACTION CONTINUING FINAL - COMPLETED
11/08/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/30/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/30/2019
ALIE
ASSIGNED TO LIE
10/30/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
10/23/2019
EXPI
EX PARTE APPEAL-INSTITUTED
10/23/2019
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
10/23/2019
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
10/23/2019
RDX3
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
07/17/2019
RDX1
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
07/17/2019
RRDX
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
07/17/2019
DPCC
DIVISIONAL PROCESSING COMPLETE
07/01/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/01/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/23/2019
GNFR
FINAL REFUSAL E-MAILED
04/23/2019
CNFR
FINAL REFUSAL WRITTEN
04/23/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/10/2019
DRRR
DIVISIONAL REQUEST RECEIVED
04/09/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/09/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/09/2019
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
04/09/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/16/2018
GNRT
NON-FINAL ACTION E-MAILED
10/16/2018
CNRT
NON-FINAL ACTION WRITTEN
10/16/2018
DOCK
ASSIGNED TO EXAMINER
10/16/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/01/2018
NWAP
NEW APPLICATION ENTERED
06/29/2018
Continuous trademark protection
Get notified about every new filing that threatens HEALIOS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.